One approach to decisively address this issue is by immunohistological staining (of anti-PAR1 and anti-PAR2 antibodies, separately) utilizing tissue microarray biopsy specimens on a large pool of primary breast cancer biopsy specimens representing invasive carcinoma. Here, F2R is linked to breast cancer.